Haverford Trust Co Sells 111,789 Shares of CVS Health Co. (NYSE:CVS)

Haverford Trust Co trimmed its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 6.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,691,529 shares of the pharmacy operator's stock after selling 111,789 shares during the period. CVS Health makes up about 1.5% of Haverford Trust Co's investment portfolio, making the stock its 24th biggest position. Haverford Trust Co owned approximately 0.13% of CVS Health worth $133,563,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Laffer Tengler Investments Inc. lifted its holdings in CVS Health by 44.1% in the fourth quarter. Laffer Tengler Investments Inc. now owns 2,065 shares of the pharmacy operator's stock valued at $163,000 after buying an additional 632 shares during the period. Addison Capital Co increased its holdings in CVS Health by 38.4% in the fourth quarter. Addison Capital Co now owns 19,520 shares of the pharmacy operator's stock valued at $1,541,000 after purchasing an additional 5,412 shares during the last quarter. Apexium Financial LP lifted its stake in CVS Health by 50.2% in the fourth quarter. Apexium Financial LP now owns 6,095 shares of the pharmacy operator's stock valued at $481,000 after buying an additional 2,038 shares during the period. ARGA Investment Management LP boosted its holdings in CVS Health by 0.8% during the fourth quarter. ARGA Investment Management LP now owns 22,349 shares of the pharmacy operator's stock worth $1,765,000 after buying an additional 173 shares during the last quarter. Finally, Inceptionr LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $334,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Insiders Place Their Bets

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now owns 21,630 shares of the company's stock, valued at approximately $1,165,424.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.24% of the company's stock.

Analysts Set New Price Targets

Several brokerages have commented on CVS. Barclays lowered their target price on shares of CVS Health from $78.00 to $63.00 and set an "equal weight" rating for the company in a research note on Thursday, May 2nd. Leerink Partnrs cut CVS Health from an "outperform" rating to a "market perform" rating in a research note on Wednesday, May 1st. SVB Leerink reaffirmed a "market perform" rating and set a $60.00 price target (down previously from $87.00) on shares of CVS Health in a research report on Wednesday, May 1st. The Goldman Sachs Group decreased their price objective on CVS Health from $85.00 to $74.00 and set a "buy" rating for the company in a research report on Thursday, May 2nd. Finally, UBS Group downgraded shares of CVS Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $85.00 to $60.00 in a report on Thursday, May 2nd. Nine investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $76.75.

CVS Health Stock Up 0.3 %

CVS stock traded up $0.16 during mid-day trading on Friday, reaching $57.68. The company had a trading volume of 9,590,732 shares, compared to its average volume of 11,929,419. The company has a market capitalization of $72.41 billion, a price-to-earnings ratio of 10.08, a PEG ratio of 0.54 and a beta of 0.56. CVS Health Co. has a 52 week low of $53.70 and a 52 week high of $83.25. The stock has a 50 day simple moving average of $69.41 and a two-hundred day simple moving average of $72.44. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts' consensus estimates of $1.69 by ($0.38). The firm had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health's quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.20 earnings per share. As a group, equities analysts predict that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.61%. The ex-dividend date was Friday, April 19th. CVS Health's payout ratio is currently 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.